What does the certification stack look like?
WHO-GMP is the floor — required for any domestic manufacturer. EU-GMP, PIC/S-GMP and US-FDA inspections are the differentiators. Imexpharm holds the largest set of EU-GMP-compliant production lines in Vietnam with 11 lines across three plant clusters [VIR 2025]. UIP earned EU-GMP at its Binh Duong VSIP-2 facility in early 2025 [Vietnam.vn 2025]. Bidiphar, DHG Pharma and Domesco are deep into EU-GMP commissioning.
What are the tender preference economics?
Circular 40/2025/TT-BYT splits tender lots into 5 tiers. Tier-1 — reserved for "high-quality drugs" — accepts EU-GMP-certified manufacturers and SRA-approved drugs [MoH 2025]. Domestic operators in Tier-1 effectively compete head-to-head with foreign-brand imports at 20-40% price discounts [Kira estimates]. The tier preference compresses foreign-brand pricing power and re-rates EU-GMP plants commercially.
What is the capex commitment window?
EU-GMP commissioning runs 18-36 months from greenfield depending on technology partner and line type [Kira estimates from operator conversations]. Plants that haven't broken ground by mid-2026 won't be certified by 2028; they cede the 2027-30 absorption wave to incumbents. Tech-transfer JVs with foreign-strategic partners compress that timeline materially.
Methodology note: EU-GMP and WHO-GMP plant counts sourced from InvestVietnam's 2025 industry directory [InvestVietnam 2025] cross-referenced against MoH's facility register and Vietnam.vn UIP certification announcement [Vietnam.vn 2025]. Tender tier preference economics are KIRA analyst estimates [Kira estimates] derived from operator conversations and Circular 40/2025/TT-BYT [MoH 2025] text analysis. EU-GMP commissioning timelines are KIRA estimates based on disclosed operator milestones. Forecasts reflect KIRA's analyst view as of May 2026. No part of this article constitutes investment advice.